Author
Icahn School of Medicine at Mount SinaiORCID 0000-0002-9311-9929Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Samarth Hegde, Bruno Giotti, Brian Y. Soong…·Miriam Mérad
The paper identifies NRF2-driven myeloid progenitor dysregulation that sustains immunosuppressive macrophages in tumors, showing NRF2 inhibition reduces their survival and enhances antitumor immunity.
Angelo Amabile, Matthew Phelan, Zhe Yu…·Brian D. Brown
This paper develops a method to conjugate bispecific antibodies to lipid nanoparticles for targeted mRNA delivery, showing improved efficiency and specificity in transfecting specific cell types.
Étienne Humblin, Isabel Korpas, Nataliya Prokhnevska…·Alice Oliffson Kamphorst
This study shows ICOS limits the function of exhausted PD-1+ CD8 T cells by promoting their differentiation into less functional effector-like cells, and inhibiting ICOS improves anti-tumor responses.